Patents by Inventor Kyle J. Bednar

Kyle J. Bednar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODY TARGETING CD22 AND CD79B
    Publication number: 20250066474
    Abstract: Provided herein are multispecific antibodies, that bind to CD79b and CD22, polynucleotides encoding them, vectors, host cells, methods of making and using them.
    Type: Application
    Filed: November 13, 2024
    Publication date: February 27, 2025
    Inventors: Kyle J. Bednar, Naresh Kumar, Sanjaya Singh, Danlin Yang, Rajkumar Ganesan
  • Antibody targeting CD22 and CD79B
    Patent number: 12180278
    Abstract: Provided herein are multispecific antibodies, that bind to CD79b and CD22, polynucleotides encoding them, vectors, host cells, methods of making and using them.
    Type: Grant
    Filed: March 23, 2022
    Date of Patent: December 31, 2024
    Assignee: Janssen Biotech, Inc.
    Inventors: Kyle J. Bednar, Naresh Kumar, Sanjaya Singh, Danlin Yang, Rajkumar Ganesan
  • ANTIBODY TARGETING CD22 AND CD79B
    Publication number: 20220306738
    Abstract: Provided herein are multispecific antibodies, that bind to CD79b and CD22, polynucleotides encoding them, vectors, host cells, methods of making and using them.
    Type: Application
    Filed: March 23, 2022
    Publication date: September 29, 2022
    Inventors: Kyle J. Bednar, Naresh Kumar, Sanjaya Singh, Danlin Yang, Rajkumar Ganesan